J&J vaccine plus Gilead immune booster shows promise as HIV fighter

By Julie Steenhuysen CHICAGO (Reuters) – An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the virus at bay in monkeys even after treatments had stopped, marking yet another step toward the development of a so-called functional cure for HIV. The study, published on Wednesday in the journal Nature, evaluated monkeys infected with simian immunodeficiency virus, the monkey version of HIV, and showed the treatments were much more effective when used together than separately. All nine monkeys that got both treatments showed significantly reduced viral loads.
Sexual Health News Headlines – Yahoo! News